TransMedics Group TMDX 深 滬
已收盤 02-06 16:00:00 美东时间
135.06
+5.460
+4.21%
華盛通- 最 高135.22
- 今 開131.03
- 成交量 53.06万股
- 最 低 131.03
- 昨 收 129.60
- 總市值 46.16亿
- 52周最高 156.00
- 市盈率 靜 134.12
- 換手率 1.55%
- 52周最低 62.0726
- 委 比 -99.89%
- 總股本 3417.43万
- 歷史最高 177.37
- 量 比 0.74
- 振 幅 3.23%
- 歷史最低 10.00
- 每 手 1
- 風險率 23.46%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多How Is The Market Feeling About TransMedics Group Inc?
TransMedics Group Inc's (NYSE:TMDX) short interest as a percent of float has fa...
01-03 00:00
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
ANDOVER, Mass., Dec. 24, 2025 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients ...
2025-12-25 05:05
Alphatec is the top performing healthcare equipment stock YTD
The S&P healthcare index (XLV) saw moderate gains in 2025, reaching a YTD increase of 12.2% by mid-December, though it fell short of its May highs. The sector is the sixth-highest performing sector a...
2025-12-23 01:12
美股大行评级 | 德银首予Coinbase"买入"评级，目标价340美元；AERO获多家机构首予超配评级；大摩维持苹果"超配"评级，目标价升至315美元
今日重点评级关注：巴克莱：维持Iovance Biotherapeutics"超配"评级，目标价从9美元升至10美元；摩根大通：上调Recursion Pharmaceuticals评级至"超配"，目标价从10美元升至11美元
2025-12-18 10:54
Canaccord Genuity Maintains Buy on TransMedics Group, Raises Price Target to $148
Canaccord Genuity analyst William Plovanic maintains TransMedics Group (NASDAQ:TMDX) with a Buy and raises the price target from $147 to $148.
2025-12-18 04:10
美股大行评级 | 潜在涨幅2566.67%！Ascendiant Capital上调GRI Bio目标价至36美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持GRI Bio"买入"评级，目标价从35美元升至36美元；Ascendiant Capital：维持Atossa Therapeutics"买入"评级，目标价从7.75美元升至8美元
2025-12-09 10:32
美股大行评级 | 最高500美元！MongoDB获18家大行紧急上调目标价；巴克莱下调理想汽车目标价至18美元
今日重点评级关注：B. Riley证券：维持Seabridge Gold"买入"评级，目标价从50美元升至65美元；HC Wainwright & Co.：维持TRX Gold"买入"评级，目标价从1.2美元升至1.4美元
2025-12-03 09:58
Morgan Stanley Maintains Equal-Weight on TransMedics Group, Raises Price Target to $135
Morgan Stanley analyst Patrick Wood maintains TransMedics Group (NASDAQ:TMDX) with a Equal-Weight and raises the price target from $123 to $135.
2025-12-03 02:01
Dycom Industries, BellRing Brands, Lumentum And Other Big Stocks Moving Higher On Wednesday
U.S. stocks were mixed, with the Nasdaq Composite gaining more than 100 points ...
2025-11-20 01:02
美股大行评级 | 最高350美元！16家大行上调谷歌目标价！Meta遭12家大行下调目标价；潜在涨幅1456.29%！NRX Pharmaceuticals获Ascendiant Capital升目标价至47美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持NRX Pharmaceuticals"买入"评级，目标价从46美元升至47美元；富国银行：维持Kyverna Therapeutics"超配"评级，目标价从27美元升至31美元
2025-10-31 10:25
